ACBM - ACRO BIOMEDICAL CO., LTD.

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	N/M	—	—	N/M	—	—	N/M	200.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3900%)	—	—	—	-85.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1811%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-324.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	8.5% Fair ↓ Fair Declining Year-over-year change in net income	8.5% Fair ↓ Fair Declining Year-over-year change in net income	8.5% Fair ↓ Fair Declining Year-over-year change in net income	41.5% Excellent ↓ Excellent Declining Year-over-year change in net income	99.7% Excellent → Excellent Stable Year-over-year change in net income	99.7% Excellent ↑ Excellent Improving Year-over-year change in net income	99.7% Excellent ↑ Excellent Improving Year-over-year change in net income	99.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.9% Weak → Weak Stable Year-over-year change in net income	-1.9% Weak ↑ Weak Improving Year-over-year change in net income	-1.9% Weak ↑ Weak Improving Year-over-year change in net income	-2.1% Weak ↑ Weak Improving Year-over-year change in net income	-6503.7% Weak → Weak Stable Year-over-year change in net income	-6503.7% Weak ↓ Weak Declining Year-over-year change in net income	-6503.7% Weak ↓ Weak Declining Year-over-year change in net income	-6137.3% Weak ↓ Weak Declining Year-over-year change in net income	6.6% Fair ↓ Fair Declining Year-over-year change in net income	6.6% Fair ↓ Fair Declining Year-over-year change in net income	N/M	18.6% Good ↓ Good Declining Year-over-year change in net income	62.5% Excellent Excellent Year-over-year change in net income	62.5% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	—	—	289.1% Excellent Excellent Year-over-year change in net income	N/M	—	—	N/M	30.6% Excellent Excellent Year-over-year change in net income	—	—	-162.2% Weak Weak Year-over-year change in net income	-95038.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-21.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-27.1% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-158.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1422%)	-57.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-577%)	—	—	—	11.9% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	—	—	—	—	—	—	—	—	—	—	—	5.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-54%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-11.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-249%)	-59.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-847%)	—	—	—	11.8% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+47%)	—	—	—	—	—	3.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-61%)	—	—	—	—	—	5.6% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-2.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	87.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-8.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-3.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-23.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.14x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	-0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	5.28x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	9.12x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.19x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.20x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	-0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-7.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-10.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Return on Invested Capital (%)	11.1% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	26.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	4.3% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	6.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	663.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-940.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-974.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-808.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-814.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-695.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-482.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-472.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-415.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-97.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	6.1% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-431.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-1556.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-116.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2662.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-592.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-609.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-572.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-597.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-539.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-506.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-474.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-113.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	8.0% Fair Fair Operating profit relative to total assets Optimal: > 10%	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	10.9% Good Good Operating profit relative to total assets Optimal: > 10%	—	—	—	7.2% Fair Fair Operating profit relative to total assets Optimal: > 10%	-2.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	3187.1% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	10.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	3.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	3.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	4.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-72%)	7.1% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-53%)	—	—	—	—	—	—	—	—	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-8.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	9.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	-8.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-19.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-17.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-219%)	-17.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	12.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	5.6% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	—	—	7.7% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-49%)	-2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	—	—	41.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+176%)	115.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+672%)	—	—	-8.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-0.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Interest Coverage (x)	—	—	—	—	-0.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-10.79x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-14710.19x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-89595.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	-80828.54x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-171.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	-218.11x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$-215.49K	$-24.36K	—	—	$-381.00	$-10.64K	$-1.47K	$-1.47K	$-231.00	$-412.00	$-1.15K	$-1.15K	$-4.62K	$-471.83K	$-36.81K	$-36.81K	—	—	$-2.53K	$-2.53K	$-2.14K	$-7.74K	$-27.27K	$-27.27K	$-28.79K	—	$-3.92K	$-3.92K

📊 What does each share earn? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Book Value per Share (USD)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	—	$0.01	$0.01	$0.01	—	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	—	—	$0.02	$0.02	—	—	—	$0.03	$0.03	$0.02	$0.01	$0.01	$0.01	$-0.00	—	$-0.00	$-0.00	$-0.00	$0.00	$0.00	$0.00	—	—	—	—
Tangible Book Value per Share (USD)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	—	$0.01	$0.01	$0.01	—	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	—	—	$0.02	$0.02	—	—	—	$0.03	$0.03	$0.02	$0.01	$0.01	$0.01	$-0.00	—	$-0.00	$-0.00	$-0.00	$0.00	$0.00	$0.00	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Working Capital (USD)	$-427.24K	$-386.96K	$-432.62K	$-331.17K	$-324.23K	$-321.87K	$-316.60K	$-307.10K	$-297.63K	$-286.95K	—	$326.67K	$391.52K	$456.42K	—	$545.45K	$614.03K	$614.76K	$561.95K	$627.73K	$610.26K	$661.17K	—	—	$849.19K	$767.93K	—	—	—	$1.24M	$1.24M	$772.33K	$656.02K	$511.33K	$511.33K	$-28.16K	—	$-14.79K	$-14.79K	$-8.67K	$8.46K	$28.64K	$28.64K	—	—	—	—
Total Equity (USD)	$-427.24K	$-386.96K	$-432.62K	$-317.52K	$-303.91K	$-294.97K	$-285.50K	$-276.40K	$-267.31K	$-257.01K	$-239.61K	$339.65K	$410.90K	$486.37K	$492.16K	$574.89K	$643.22K	$643.71K	$568.22K	$640.21K	$628.88K	$685.87K	$745.48K	$817.02K	$879.80K	$873.67K	$873.67K	$948.00K	$998.22K	$1.24M	$1.24M	$777.32K	$661.01K	$511.33K	$511.33K	$-28.16K	—	$-14.79K	$-14.79K	$-8.67K	$8.46K	$28.64K	$28.64K	—	—	$3.92K	—

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Sep 30, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Sep 30, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2017 10-Q ↗	Q4 FY2016 Sep 30, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Sep 30, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Dec 31, 2015 10-Q ↗	Q4 FY2014 Sep 30, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$360.00K	$0.00	$0.00	$298.50K	—	$0.00	$500.00K	$99.50K	—	$0.00	$0.00	$687.96K	—	—	—	—	—	$2.20M	—	—	—	—	—	$1.45M	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-43.77K	$42.53K	$-10.30K	$-10.30K	$-10.30K	$-10.67K	$-11.25K	$-11.25K	$-11.25K	$-18.24K	$-4.00M	$-4.00M	$-4.00M	$-3.93M	$-3.93M	$-3.93M	$-3.93M	$-3.85M	$-59.49K	$-59.49K	$-59.49K	$-61.77K	$-63.70K	$-63.70K	$81.12K	$-75.87K	$-169.75K	$-169.75K	$-169.75K	$153.67K	$69.45K	—	—	$39.49K	$-11.89K	—	$80.23K	$-6.13K	$-17.12K	—	—	$-2.34K	$-18.00	—	$-13.83K	—	—
Operating Cash Flow (USD)	$-49.82K	$-25.38K	$-54.41K	$-93.98K	$-22.53K	$-10.52K	—	—	$-13.51K	$-12.61K	$483.00	—	$-5.57K	$-10.57K	$-53.27K	—	$262.13K	$-60.51K	—	—	$-8.38K	$-37.01K	$-64.60K	$-71.83K	$-26.01K	$34.93K	$42.87K	$-85.18K	$-52.34K	$-4.17K	$-512.36K	—	—	$-416.18K	—	—	—	—	—	—	—	—	—	—	—	—	—

ACRO BIOMEDICAL CO., LTD.

Analytical Summary

47-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACBM with peers